The Quest for the Hepatitis C Virus Holy Grail by Maryam Tabatabai June 19, 2017Breakthrough Therapy Designation, Genotypes, HCV, Hepatits C, Magellan Health, Magellan Rx Management, Pangenotypic
Do You Know the Truth about Trend? by Magellan Health Insights June 5, 2017Magellan Rx Management, Medical Pharmacy, Pharmacy Spend, Specialty, Trend
What do Employers Need to Know about Escalating Specialty Drug Spend? by Kathy Campagna May 24, 2017Autoimmune, Employers, Magellan Rx Management, Medical Benefit, Oncology, PBM, Rare Diseases, Specialty Pharmacy
Six Ways to Keep Specialty Spend Under Control by Magellan Health Insights March 31, 2017Magellan Rx Management, Matt Ward, Medical Pharmacy, Oncology, PBM, Pharmacy Benefits Management, Specialty Pharmacy
Connecting Key Opinion Leaders with Prescribing Doctors – Enhancing Dialogue and Discussion by Maryam Tabatabai March 8, 2017Clinical Connections, Key Opinion Leader, Magellan Rx Management, Muscular Dystrophy, Rare Diseases
Managing Transformation Across Healthcare: Key Highlights from MOVE 2017 by Magellan Health Insights February 23, 2017Billy Millwee, Chet Burrell, Magellan Health, Magellan Healthcare, Magellan Open Vision Exchange, Michael Leavitt, MOVE, Sam Srivastava, Scottsdale, Transformation, Value-Based Care
Value-Based Purchasing: Putting the Wheels into Motion by Monica Collins January 13, 2017Assertive Community Treatment, Collaboration, Engagement, Innovation, Magellan Health, Magellan Healthcare, Monica Collins, Pennsylvania
Learn More: Magellan Rx Management’s Medicaid Trend Report Webinar by Magellan Rx Management December 6, 2016Doug Brown, Fee-for-Service, Formulary, Magellan Rx Management, Medicaid, Pharmacy
